Certara, Inc.

NasdaqGS:CERT Stock Report

Market Cap: US$2.2b

Certara Management

Management criteria checks 3/4

Certara's CEO is Bill Feehery, appointed in Jun 2019, has a tenure of 6.33 years. total yearly compensation is $7.22M, comprised of 11% salary and 89% bonuses, including company stock and options. directly owns 1.45% of the company’s shares, worth $31.78M. The average tenure of the management team and the board of directors is 2.4 years and 6.3 years respectively.

Key information

Bill Feehery

Chief executive officer

US$7.2m

Total compensation

CEO salary percentage11.02%
CEO tenure6.3yrs
CEO ownership1.5%
Management average tenure2.4yrs
Board average tenure6.3yrs

Recent management updates

Recent updates

A Look At The Fair Value Of Certara, Inc. (NASDAQ:CERT)

Sep 04
A Look At The Fair Value Of Certara, Inc. (NASDAQ:CERT)

Shareholders Will Be Pleased With The Quality of Certara's (NASDAQ:CERT) Earnings

Aug 14
Shareholders Will Be Pleased With The Quality of Certara's (NASDAQ:CERT) Earnings

Some Investors May Be Worried About Certara's (NASDAQ:CERT) Returns On Capital

Aug 08
Some Investors May Be Worried About Certara's (NASDAQ:CERT) Returns On Capital

Risks To Shareholder Returns Are Elevated At These Prices For Certara, Inc. (NASDAQ:CERT)

Jul 18
Risks To Shareholder Returns Are Elevated At These Prices For Certara, Inc. (NASDAQ:CERT)

Is Certara (NASDAQ:CERT) Using Too Much Debt?

Jun 27
Is Certara (NASDAQ:CERT) Using Too Much Debt?
User avatar

FDA Phaseout And AI Integration Will Expand Biosimulation Demand

Regulatory shifts and long-term outsourcing trends are boosting demand for Certara's biosimulation and data-driven modeling solutions, supporting recurring revenue growth and market expansion.

Certara (NASDAQ:CERT) Will Be Hoping To Turn Its Returns On Capital Around

May 07
Certara (NASDAQ:CERT) Will Be Hoping To Turn Its Returns On Capital Around

Certara, Inc.'s (NASDAQ:CERT) 32% Price Boost Is Out Of Tune With Revenues

Apr 15
Certara, Inc.'s (NASDAQ:CERT) 32% Price Boost Is Out Of Tune With Revenues

Buy Certara After The FDA Announcement

Apr 11

Why Certara, Inc. (NASDAQ:CERT) Could Be Worth Watching

Mar 29
Why Certara, Inc. (NASDAQ:CERT) Could Be Worth Watching

Here's Why Certara (NASDAQ:CERT) Can Manage Its Debt Responsibly

Feb 27
Here's Why Certara (NASDAQ:CERT) Can Manage Its Debt Responsibly

Certara, Inc.'s (NASDAQ:CERT) Share Price Not Quite Adding Up

Jan 11
Certara, Inc.'s (NASDAQ:CERT) Share Price Not Quite Adding Up

Is Certara, Inc. (NASDAQ:CERT) Worth US$10.9 Based On Its Intrinsic Value?

Dec 19
Is Certara, Inc. (NASDAQ:CERT) Worth US$10.9 Based On Its Intrinsic Value?

Certara (NASDAQ:CERT) Is Reinvesting At Lower Rates Of Return

Nov 15
Certara (NASDAQ:CERT) Is Reinvesting At Lower Rates Of Return

Is Certara, Inc. (NASDAQ:CERT) Potentially Undervalued?

Oct 24
Is Certara, Inc. (NASDAQ:CERT) Potentially Undervalued?

Certara (NASDAQ:CERT) Seems To Use Debt Quite Sensibly

Sep 20
Certara (NASDAQ:CERT) Seems To Use Debt Quite Sensibly

Certara: Still Awaiting Consistent Growth

Sep 16

Certara, Inc. (NASDAQ:CERT) Shares Could Be 35% Above Their Intrinsic Value Estimate

Aug 31
Certara, Inc. (NASDAQ:CERT) Shares Could Be 35% Above Their Intrinsic Value Estimate

There's Reason For Concern Over Certara, Inc.'s (NASDAQ:CERT) Price

Jul 18
There's Reason For Concern Over Certara, Inc.'s (NASDAQ:CERT) Price

Certara (NASDAQ:CERT) Is Looking To Continue Growing Its Returns On Capital

Jun 13
Certara (NASDAQ:CERT) Is Looking To Continue Growing Its Returns On Capital

When Should You Buy Certara, Inc. (NASDAQ:CERT)?

Apr 11
When Should You Buy Certara, Inc. (NASDAQ:CERT)?

Certara, Inc.'s (NASDAQ:CERT) Share Price Could Signal Some Risk

Mar 21
Certara, Inc.'s (NASDAQ:CERT) Share Price Could Signal Some Risk

Returns Are Gaining Momentum At Certara (NASDAQ:CERT)

Feb 17
Returns Are Gaining Momentum At Certara (NASDAQ:CERT)

Certara: Applied BioMath Acquisition And Simcyp Launch Should Drive Growth

Jan 30

Calculating The Fair Value Of Certara, Inc. (NASDAQ:CERT)

Dec 07
Calculating The Fair Value Of Certara, Inc. (NASDAQ:CERT)

Risks To Shareholder Returns Are Elevated At These Prices For Certara, Inc. (NASDAQ:CERT)

Oct 31
Risks To Shareholder Returns Are Elevated At These Prices For Certara, Inc. (NASDAQ:CERT)

Is It Time To Consider Buying Certara, Inc. (NASDAQ:CERT)?

Sep 17
Is It Time To Consider Buying Certara, Inc. (NASDAQ:CERT)?

An Intrinsic Calculation For Certara, Inc. (NASDAQ:CERT) Suggests It's 29% Undervalued

Aug 30
An Intrinsic Calculation For Certara, Inc. (NASDAQ:CERT) Suggests It's 29% Undervalued

CEO Compensation Analysis

How has Bill Feehery's remuneration changed compared to Certara's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2025n/an/a

US$8m

Mar 31 2025n/an/a

-US$3m

Dec 31 2024US$7mUS$796k

-US$12m

Sep 30 2024n/an/a

-US$31m

Jun 30 2024n/an/a

-US$79m

Mar 31 2024n/an/a

-US$61m

Dec 31 2023US$8mUS$796k

-US$55m

Sep 30 2023n/an/a

-US$34m

Jun 30 2023n/an/a

US$19m

Mar 31 2023n/an/a

US$14m

Dec 31 2022US$6mUS$796k

US$15m

Sep 30 2022n/an/a

-US$4m

Jun 30 2022n/an/a

-US$10m

Mar 31 2022n/an/a

-US$12m

Dec 31 2021US$6mUS$773k

-US$13m

Sep 30 2021n/an/a

-US$58m

Jun 30 2021n/an/a

-US$55m

Mar 31 2021n/an/a

-US$49m

Dec 31 2020US$4mUS$773k

-US$49m

Sep 30 2020n/an/a

-US$965k

Jun 30 2020n/an/a

US$601k

Mar 31 2020n/an/a

-US$5m

Dec 31 2019US$4mUS$438k

-US$9m

Compensation vs Market: Bill's total compensation ($USD7.22M) is above average for companies of similar size in the US market ($USD5.53M).

Compensation vs Earnings: Bill's compensation has been consistent with company performance over the past year.

CEO

Bill Feehery (54 yo)

6.3yrs
Tenure
US$7,219,615
Compensation

Dr. William F. Feehery, also known as Bill, Ph.D. serves as Chief Executive Officer of the Certara, Inc. since June 2019 and Director since 2012. He had been the President of Industrial Biosciences Busines...

Leadership Team

NamePositionTenureCompensationOwnership
William Feehery
CEO & Director6.3yrsUS$7.22m1.45%
$ 31.8m
Leif Pedersen
President & Chief Commercial Officer2.2yrsUS$2.06m0.046%
$ 1.0m
John Gallagher
SVP, Principal Accounting Officer & Chief Financial Officer2.5yrsUS$2.95m0.029%
$ 632.8k
Robert Aspbury
President of Certara Predictive Technologies5.8yrsUS$2.02m0.19%
$ 4.2m
Christopher Bouton
Chief Technology Officerless than a yearno datano data
Daniel Corcoran
Senior VP & General Counsel1.4yrsno data0.010%
$ 220.6k
Ron DiSantis
Senior Vice President of Corporate Developmentno datano datano data
Sheila Rocchio
Chief Marketing Officer2.3yrsno datano data
Rona Anhalt
Chief Human Resources Officer1.4yrsno data0.0032%
$ 70.6k
Frederic Bois
Senior Scientific Advisor6.5yrsno datano data
David Mitchell
Senior Vice President of Strategic Engagement4.1yrsno datano data
Hannah Jones
Senior VP & Head of PBPK Consulting Servicesno datano datano data
2.4yrs
Average Tenure
56yo
Average Age

Experienced Management: CERT's management team is considered experienced (2.4 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
William Feehery
CEO & Director6.3yrsUS$7.22m1.45%
$ 31.8m
Frederic Bois
Senior Scientific Advisor6.5yrsno datano data
James Cashman
Independent Chairman of the Board7.4yrsUS$319.48k0.29%
$ 6.4m
Matthew Walsh
Independent Director5.2yrsUS$251.98k0.12%
$ 2.7m
Eran Broshy
Independent Director3.3yrsUS$251.98k0.022%
$ 475.3k
Malcolm Rowland
Chair of Simcyp Scientific Advisory Boardno datano datano data
Yuichi Sugiyama
Member of Simcyp Scientific Advisory Boardno datano datano data
Nancy Killefer
Independent Director4.2yrsUS$251.98k0.022%
$ 490.9k
Donald Mager
Member of Simcyp Scientific Advisory Boardno datano datano data
Geoff Tucker
Member of Simcyp Scientific Advisory Boardno datano datano data
Lawrence Lesko
Member of Simcyp Scientific Advisory Board10.2yrsno datano data
J Houston
Member of Simcyp Scientific Advisory Boardno datano datano data
6.3yrs
Average Tenure
66yo
Average Age

Experienced Board: CERT's board of directors are considered experienced (6.3 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/10/03 20:31
End of Day Share Price 2025/10/03 00:00
Earnings2025/06/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Certara, Inc. is covered by 18 analysts. 11 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Joseph VruwinkBaird
Luke SergottBarclays
Andrew MossBofA Global Research